Jinqiu (Edward) Tang
Chief Financial Officer
Mr. Jinqiu (Edward) Tang has served as Anpac Bio’s Corporate Controller since October 2019 before becoming Chief Financial Officer. His experience includes:
Our world class leaders started with a question, “What if we could detect cancer before tumors start?”
Our patented Cancer Differentiation Analysis (CDA) technology reinvents cancer screening and early detection with a “Blood Biopsy” that has no side effects in patients.
*As of September 30, 2019
Read about our CDA technology at the Nobel Prize Laureate Summit on Biomedical Science (NPLS) publications.Read the full article